Cargando…
Is There a (Host) Genetic Predisposition to Progressive Multifocal Leukoencephalopathy?
Progressive multifocal leukoencephalopathy (PML) has been described in association with a variety of predisposing risk factors, including HIV/AIDS, lymphoproliferative disorders and, most recently, treatment with a range of biologics, most notably natalizumab in multiple sclerosis (MS) (1). However,...
Autor principal: | Hatchwell, Eli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426763/ https://www.ncbi.nlm.nih.gov/pubmed/26029204 http://dx.doi.org/10.3389/fimmu.2015.00216 |
Ejemplares similares
-
Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy
por: Eis, Peggy S., et al.
Publicado: (2020) -
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
por: Hatchwell, Eli, et al.
Publicado: (2022) -
B Cells and Progressive Multifocal Leukoencephalopathy: Search for the Missing Link
por: Durali, Deniz, et al.
Publicado: (2015) -
Progressive Multifocal Leukoencephalopathy
por: Adang, Laura, et al.
Publicado: (2015) -
The Importance of Mouse Models to Define Immunovirologic Determinants of Progressive Multifocal Leukoencephalopathy
por: Frost, Elizabeth L., et al.
Publicado: (2015)